RNAi-mediated silencing of insulin receptor substrate-4 enhances actinomycin D- and tumor necrosis factor-alpha-induced cell death in hepatocarcinoma cancer cell lines.
Cuevas, Eva P
RNAi-mediated silencing of insulin receptor substrate-4 enhances actinomycin D- and tumor necrosis factor-alpha-induced cell death in hepatocarcinoma cancer cell lines. [electronic resource] - Journal of cellular biochemistry Dec 2009 - 1292-301 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1097-4644
10.1002/jcb.22359 doi
Antineoplastic Combined Chemotherapy Protocols--pharmacology
Apoptosis
Carcinoma, Hepatocellular--metabolism
Dactinomycin--pharmacology
Humans
Immunohistochemistry
Insulin Receptor Substrate Proteins--antagonists & inhibitors
Liver Neoplasms--metabolism
RNA Interference
Tumor Necrosis Factor-alpha--pharmacology
RNAi-mediated silencing of insulin receptor substrate-4 enhances actinomycin D- and tumor necrosis factor-alpha-induced cell death in hepatocarcinoma cancer cell lines. [electronic resource] - Journal of cellular biochemistry Dec 2009 - 1292-301 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1097-4644
10.1002/jcb.22359 doi
Antineoplastic Combined Chemotherapy Protocols--pharmacology
Apoptosis
Carcinoma, Hepatocellular--metabolism
Dactinomycin--pharmacology
Humans
Immunohistochemistry
Insulin Receptor Substrate Proteins--antagonists & inhibitors
Liver Neoplasms--metabolism
RNA Interference
Tumor Necrosis Factor-alpha--pharmacology